Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a new page version. This change does not modify the study details or other content on the page.
    Difference
    0.1%
    Check dated 2026-05-16T09:12:26.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s displayed “Revision” version number was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:39:57.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, and the previous Revision: v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:06.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T23:52:17.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision status updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:16:48.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:02.000Z thumbnail image

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.